The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury.
Kevin AkeretRaphael M BuzziMoritz SaxenhoferKathrin BieriDeborah ChiaviBart R ThomsonManuela Grüttner-DurmazNina SchwendingerRok HumarLuca RegliTristan P C van DoormaalUlrike HeldEmanuela KellerMichael HugelshoferDominik J Schaernull nullPublished in: BMC neurology (2022)
ClinicalTrials.gov Identifier NCT04998370 . Date of registration: August 10, 2021.